Clemastine
- TRADE NAMES: Aller-Eze; Antihist-1; Clema; Darvine; Tavegil; Tavegyl; Tavist (Novartis)
- INDICATIONS: Allergic rhinitis, urticaria
- CLASS: Histamine H1 receptor antagonist
- HALF-LIFE: 4–6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Barbiturates, Chloral Hydrate, Ethchlorvynol, Phenothiazines, Zolpidem
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
NEUROMUSCULAR/SKELETAL.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric